Sort
82,697 grants matching “vaccine development”
Molecular Genetics Of Scrapie Pathogenesis
$1,145,487Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Vector-Borne Diseases: Biology Of Vector Host Relationship
$1,145,474Jose Ribeiro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Development of botulinum neurotoxin immunotherapy
$1,145,202James D. Marks · University Of California, San Francisco · U01 · FY2006 · AI
High throughput NAPPA-proteoimmunomics and Vibrio cholerae vaccine development
$1,144,934Edward T. Ryan · Massachusetts General Hospital · U01 · FY2011 · AI
Comprehensive Minority and Health Disparities Research Center - Phase III
$1,144,930Mona N. Fouad · University Of Alabama At Birmingham · P60 · FY2013 · MD
Collaborative Modeling for Assessment and Optimization in Public Health
$1,144,898Marc Lipsitch · Harvard School Of Public Health · U54 · FY2014 · GM
New Strategies to Prevent Death from Influenza
$1,144,813Kendall A Smith · Weill Medical Coll Of Cornell Univ · U01 · FY2008 · AI
Optimization and preclinical development of a TB Multiple Antigen Presenting System (MAPS) vaccine
$1,144,476Richard Malley · Boston Children'S Hospital · R01 · FY2022 · AI
Core C - The University of Texas Medical Branch at Galveston
$1,144,444Thomas William Geisbert · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2021 · AI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)-mRNA-1273-P204 Moderna Pediatric Study
$1,144,400Ann R Falsey · University Of Rochester · UM1 · FY2021 · AI
III: Medium: Ask the Experts: Generating Question-Answer Pairs for Addressing Information Deficits about Vaccines
$1,144,224Bhuwan Dhingra · Duke University · · FY2022 · CSE
Personalized Cystic Fibrosis Therapy and Research Center
$1,144,093Anjaparavanda P Naren · Cincinnati Childrens Hosp Med Ctr · P30 · FY2021 · DK
Tfh and B cells in HIV/SIV pathogenesis and vaccination
$1,143,986Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Tfh and B cells in HIV/SIV pathogenesis and vaccination
$1,143,986Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Development of Nonhuman Primate Model of MERS-CoV
$1,143,846National Institute Of Allergy And Infectious Diseases · Y01 · FY2019 · AI
Immunobiology of Influenza Virus-related Critical Illness in Young Hosts
$1,143,757Adrienne G Randolph · Boston Children'S Hospital · R01 · FY2021 · AI
Malaria Parasite Ligands And Host Cell Receptors
$1,143,717Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Characterize HIV-Infected T-Cell Clones on ART and Impact of Experimental Interventions
$1,143,693Mary Kearney · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Protein-mediated membrane remodeling
$1,143,528Leonid V. Chernomordik · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2010 · HD
Chlamydial Immunity and Vaccine Development
$1,143,479Harlan D Caldwell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Shigella Conjugate Vaccine (SCV4) Development, Characterization, and Pre-clinical Evaluation
$1,143,199Edward T. Ryan · Massachusetts General Hospital · R01 · FY2025 · AI
LcrV Plague Vaccine with Altered Immune Modulatory Properties
$1,143,017Olaf Schneewind · University Of Chicago · U01 · FY2006 · AI
Structure-Based Vaccine Design for Hepatits C Virus
$1,142,860Thomas R Fuerst · Univ Of Maryland, College Park · R01 · FY2018 · AI
Malaria Vaccines: AMA1-C1/ISA 720
$1,142,572Louis Miller · Niaid Extramural Activities · Z01 · FY2007 · AI
Cornell Clinical Trials Unit
$1,142,381Roy M Gulick · Weill Medical Coll Of Cornell Univ · U01 · FY2007 · AI